1. Home
  2. STIM

as 11-20-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Founded: 2003 Country:
United States
United States
Employees: N/A City: MALVERN
Market Cap: 29.4M IPO Year: 2018
Target Price: $4.67 AVG Volume (30 days): 795.3K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.23 EPS Growth: N/A
52 Week Low/High: $0.52 - $5.07 Next Earning Date: 11-12-2024
Revenue: $72,711,000 Revenue Growth: 5.03%
Revenue Growth (this year): 11.4% Revenue Growth (next year): 12.09%

STIM Daily Stock ML Predictions

Stock Insider Trading Activity of Neuronetics Inc. (STIM)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
MACAN WILLIAM ANDREW STIM EVP, GC, CCO and CS Oct 8 '24 Sell $0.82 1,541 $1,263.62 402,792
Furlong Stephen STIM EVP, CFO and Treasurer Oct 8 '24 Sell $0.82 1,368 $1,121.76 497,408
CASCELLA ROBERT STIM Director Sep 12 '24 Buy $0.75 100,000 $75,000.00 453,098
MUIR GLENN P STIM Director Sep 5 '24 Buy $0.80 25,000 $20,000.00 289,818
MUIR GLENN P STIM Director Aug 28 '24 Buy $0.85 25,000 $21,250.00 289,818

Share on Social Networks: